Retrospective pharmaceutical financial benefits and cost avoidance analysis of clinical trial participation in the Australian haematology setting-Reference-Cited by-同舟云学术

Retrospective pharmaceutical financial benefits and cost avoidance analysis of clinical trial participation in the Australian haematology setting

Published:2019-09 Issue:9 Volume:49 Page:1092-1098
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Truong Kelvin¹^ORCID,Kwan Yiu Lam²,Nigro Lucia³,Huseincehajic Admir²,Trotman Judith¹²^ORCID

Affiliation:

1. Concord Clinical SchoolThe University of Sydney Sydney New South Wales Australia

2. Department of HaematologyConcord Repatriation General Hospital Sydney New South Wales Australia

3. Clinical Trials PharmacyConcord Repatriation General Hospital Sydney New South Wales Australia

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.14302

Reference32 articles.

1. MurphyL MaguireW. Uncovering stakeholder perceptions to reinvigorate benefit‐cost analysis. Perth: Accounting and Finance Association of Australia and New Zealand; 2013.

2. Expenditure and Prescriptions. Twelve Months to 30 June 2017. Canberra: PBS Information Management Section. Pricing and Policy Branch; 2018 [cited 2018 Mar 1]. Available from URL:http://www.pbs.gov.au/statistics/expenditure-prescriptions/2016-2017/expenditure-and-prescriptions-twelve-months-to-30-june-2017.pdf

3. Rising cost of anticancer drugs in Australia

4. Economic benefits of investigational drug services at an academic institution

5. Estimation of Drug Cost Avoidance and Pathology Cost Avoidance through Participation in NCIC Clinical Trials Group Phase III Clinical Trials in Canada

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical cost savings from the treatment of oncology patients in clinical trials;Biomedical Journal;2024-04

2. The economic impact of compassionate use of medicines;BMC Health Services Research;2021-12

3. Author reply;Internal Medicine Journal;2020-06

4. Primary objective of Concord Haematology Clinical Research Unit is to contribute independently to quality clinical research;Internal Medicine Journal;2020-06

5. Erratum;Internal Medicine Journal;2019-11